Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.75 USD | +4.17% | -1.37% | +2.04% |
2023 | NGM Biopharmaceuticals Says Phase 2b Trial of Potential Cirrhosis Treatment Meets Primary Endpoint | MT |
2023 | Alpine 4 Holdings, Inc.(NasdaqCM:ALPP) dropped from S&P Global BMI Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.04% | 19.45M | |
+14.13% | 110B | |
-1.86% | 28.8B | |
+15.90% | 22.19B | |
-12.51% | 18.27B | |
-7.36% | 17.5B | |
+15.53% | 15.92B | |
-4.17% | 11.75B | |
-1.88% | 10.61B | |
-4.52% | 9.65B |
- Stock Market
- Equities
- ALPP Stock
- News Alpine 4 Holdings, Inc.
- Alpine 4 Holdings Unit Secures $2.5 Million Orders in First Week of July